Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cyclin-Dependent Kinases

Items 31-40 of 69

Page
per page
  1. Ro 3306
    A8885 Ro 3306
     23 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  2. THZ1
    A8882 THZ1
     26 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Covalent CDK7 inhibitor,potent and selective
      ≥28.3 mg/mL
  3. CCT251545 analogue
    A8739 CCT251545 analogue
    Summary: Potent, Selective, orally bioavailable CDK 8/19 Inhibitor
      ≥20.7 mg/mL
  4. THZ531
    A8736 THZ531
    Target: Cyclin-Dependent Kinases
    Summary: CDK12 and CDK13 covalent inhibitor
      ≥55.8 mg/mL
  5. GX-674
    A8718 GX-674
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: Nav1.7 antagonist
      Soluble in DMSO
  6. THZ2
    A8717 THZ2
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥28.3 mg/mL
  7. WHI-P180
    A8643 WHI-P180
    Summary: EGFR/Janus Kinase 3 inhibitor
      Soluble in DMSO
  8. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO
  9. LEE011
    A8641 LEE011
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
  10. Flavopiridol hydrochloride
    A8640 Flavopiridol hydrochloride
    Summary: CDK inhibitor, potent and selective
      ≥21.9 mg/mL

Items 31-40 of 69

Page
per page